LeadIQ logo
Learn more at LeadIQ.com

Insights

Strategic Partnerships Absci has recently partnered with reputable organizations such as Memorial Sloan Kettering Cancer Center (MSK) and Cancer Treatment Centers of America, Inc. These partnerships can be leveraged as entry points for collaborations, joint ventures, or cross-selling opportunities.

Recent Expansion The $86.4 million funding received by Absci through a public stock offering indicates financial stability and growth potential. This recent financial boost presents an opportunity to target Absci for high-value solutions that cater to their expanding operations and technology needs.

Key Personnel Acquisitions Absci's strategic hiring of industry leaders like Professor Sir Mene Pangalos and Andreas Busch signifies a focus on innovation and expertise. Engaging with these key personnel could open avenues for offering specialized consulting services or tailor-made solutions.

Breakthrough Therapeutics Vision With a vision to deliver breakthrough therapeutics quickly and efficiently by combining AI technology with wet lab capabilities, Absci aligns with the market trend of advanced drug discovery methods. Positioning solutions that enhance their drug creation process could resonate well with Absci's objectives.

Competitive Landscape Identifying Absci's competitors like ProteinQure, Carmot Therapeutics, Exscientia, and Healx provides insights into the market landscape. Tailoring competitive analysis reports or comparative studies could help Absci in benchmarking and staying ahead in the competitive biotechnology research industry.

Similar companies to Absci

Absci Tech Stack

Absci uses 8 technology products and services including Varnish, Docker, cdnjs, and more. Explore Absci's tech stack below.

  • Varnish
    Caching
  • Docker
    Containerization
  • cdnjs
    Content Delivery Network
  • PostgreSQL
    Database
  • Atlassian Jira
    Issue Trackers
  • Chart.js
    Javascript Graphics
  • Coupa
    Travel And Expense Management
  • Linkedin
    Widgets

Media & News

Absci's Email Address Formats

Absci uses at least 2 format(s):
Absci Email FormatsExamplePercentage
FLast@abscibio.comJDoe@abscibio.com
85%
Last@abscibio.comDoe@abscibio.com
14%
FMiddleLast@abscibio.comJMichaelDoe@abscibio.com
1%
FLast@absci.comJDoe@absci.com
96%
Last@absci.comDoe@absci.com
2%
FMiddleLast@absci.comJMichaelDoe@absci.com
1%
First@absci.comJohn@absci.com
1%

Frequently Asked Questions

Where is Absci's headquarters located?

Minus sign iconPlus sign icon
Absci's main headquarters is located at Vancouver, Washington 98683 US. The company has employees across 5 continents, including North AmericaEuropeAfrica.

What is Absci's phone number?

Minus sign iconPlus sign icon
You can contact Absci's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Absci's stock symbol?

Minus sign iconPlus sign icon
Absci is a publicly traded company; the company's stock symbol is ABSI.

What is Absci's official website and social media links?

Minus sign iconPlus sign icon
Absci's official website is absci.com and has social profiles on LinkedIn.

How much revenue does Absci generate?

Minus sign iconPlus sign icon
As of October 2024, Absci's annual revenue reached $35M.

What is Absci's SIC code NAICS code?

Minus sign iconPlus sign icon
Absci's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Absci have currently?

Minus sign iconPlus sign icon
As of October 2024, Absci has approximately 184 employees across 5 continents, including North AmericaEuropeAfrica. Key team members include Chief Innovation Officer: A. B.Chief Financial Officer & Chief Business Officer: Z. J.Chief Legal Officer: S. W.. Explore Absci's employee directory with LeadIQ.

What industry does Absci belong to?

Minus sign iconPlus sign icon
Absci operates in the Biotechnology Research industry.

What technology does Absci use?

Minus sign iconPlus sign icon
Absci's tech stack includes VarnishDockercdnjsPostgreSQLAtlassian JiraChart.jsCoupaLinkedin.

What is Absci's email format?

Minus sign iconPlus sign icon
Absci's email format typically follows the pattern of . Find more Absci email formats with LeadIQ.

How much funding has Absci raised to date?

Minus sign iconPlus sign icon
As of October 2024, Absci has raised $86M in funding. The last funding round occurred on Feb 27, 2024 for $86M.

When was Absci founded?

Minus sign iconPlus sign icon
Absci was founded in 2011.
Absci

Absci

Biotechnology ResearchWashington, United States51-200 Employees

Absci is a generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster. Our Integrated Drug Creation™ platform unlocks the potential to accelerate time to clinic and increase the probability of success by simultaneously optimizing multiple drug characteristics important to both development and therapeutic benefit. With the data to learn, the AI to create, and the wet lab to validate, we can screen billions of cells per week, allowing us to go from AI-designed antibodies to wet lab-validated candidates in as little as six weeks. Our vision is to deliver breakthrough therapeutics at the click of a button, for everyone. 

Section iconCompany Overview

Headquarters
Vancouver, Washington 98683 US
Phone number
Website
absci.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
ABSI
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2011
Employees
51-200

Section iconFunding & Financials

  • $86M

    Absci has raised a total of $86M of funding over 11 rounds. Their latest funding round was raised on Feb 27, 2024 in the amount of $86M.

  • $10M$50M

    Absci's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $86M

    Absci has raised a total of $86M of funding over 11 rounds. Their latest funding round was raised on Feb 27, 2024 in the amount of $86M.

  • $10M$50M

    Absci's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.